Header graphic for print
Dangerous Drugs & Medical Devices News & Commentary on Prescription Drug & Medical Device Lawsuits

Monthly Archives: April 2013

Complications of Transvaginal Mesh Use

Posted in Vaginal Mesh

In 2008, Dr. Rebecca U. Margulies et al. published a report in The American Journal of Obstetrics and Gynecology that discussed complications requiring surgery following vaginal mesh kit procedures for prolapse.  Aptly so, the article is titled “Complications requiring reoperation following vaginal mesh kit procedures for prolapse” and that original research showing the danger of… Continue Reading

Rates of Complication with Transvaginal Mesh Exceedingly High

Posted in Vaginal Mesh

A report by Dr. Gouri B. Diwadkar et al. (2009) published in Obstetrics and Gynecology has found that rates of complication with the use of transvaginal mesh products is unacceptably high, reaching levels of more than 19%.[1] Retrospectively analyzing previously-published studies of the safety and efficacy of transvaginal mesh that used more than 50 participants between… Continue Reading

ABC News: “Elderly Abused at 1 in 3 Nursing Homes”

Posted in Public Health

ABC News recently published a report investigating the ongoing problem of nursing home abuse, revealing that the “elderly [are] abused at 1 in 3 nursing homes“.  Currently, about two million Americans reside in long-term nursing care facilities, thus placing over 600,000 elderly persons at risk for abuse. “Numerous” cases of “serious, physical, sexual and verbal abuse”… Continue Reading

Nursing Home Abuse Lawsuit Information

Posted in Public Health

Nursing Home Abuse and Neglect Overview Nursing Home abuse and neglect continue to be serious problems affecting some of our nation’s most vulnerable.  About two million Americans are currently receiving long-term care at a nursing home facility, and all too often, the rights of residents are infringed upon by nursing home staff.   Choosing to live… Continue Reading

10% Rate of Vaginal Mesh Erosion with Transvaginal Mesh

Posted in Vaginal Mesh

Recently, an article published in the British Journal of Obstetrics and Gynecology has shown that while transvaginal mesh products are effective in the treatment of damaged uterine or vaginal walls following pelvic organ prolapse, these products carry a risk of mesh erosion as high as 10%.[1] Analyzing federal databases that keep medical records from 1950… Continue Reading

Complications in the removal of transvaginal mesh

Posted in Vaginal Mesh

A recent article published in a 2011 edition of International Urogynecology Journal titled “Surgical management of mesh-related complications after prior pelvic flood reconstructive surgery with mesh” by Myrthe M. Tijdink et al. reviews possible complications of transvaginal mesh after its use in reconstructive surgery in pelvic organ prolapse or another ailment. This study retrospectively analyzed mesh-related complications… Continue Reading

Complications of Transvaginal Mesh: a case report

Posted in Vaginal Mesh

An article published in a 2006 edition of the medical journal Scandinavian Journal of Infectious Diseases by Stavros Athanasiou et al titled “Vaginal mesh infection due to Bacteroides melaninogenicus: A case report of another emerging foreign body related infection” details the case of a woman who used transvaginal mesh mesh and subsequently experienced severe infection as… Continue Reading

Silicone Transvaginal Mesh “Major Complication” Rate Over 20%

Posted in Vaginal Mesh

A recent publication by medical researchers Fred E. Govier et al. in the journal Adult Urology has revealed a shockingly high rate of complication when using transvaginal mesh, a synthetic tissue product used in vaginal reconstructive surgery and other procedures. The piece, titled “High Complication Rate Identified in Sacrocolpopexy Patients Attributed to Silicone Mesh” analyzed… Continue Reading

Large Study Shows Danger of Transvaginal Mesh

Posted in Vaginal Mesh

Published in a 2012 edition of Indian Journal of Urology, an article by Gopal Badlani et al. titled “Mesh complications in female pelvic floor reconstructive surgery and their management: A systematic review” reviews the safety and efficacy of transvaginal surgical mesh, a synthetic tissue substance used to repair the vaginal wall in reconstructive surgery.  The… Continue Reading

FDA won’t say which drugs on the market were approved based on fraudulent research

Posted in Drug Studies, FDA Regulation

This shows that the FDA is more interested in protecting pharmaceutical companies than patients.  Note how Woodcock doesn’t want to force new trials because that requires human experimentation, which has risk.  A smarter regulator would realize that the risks increase in proportion to the size of the user base of the drug.  And allowing any… Continue Reading

Transvaginal Mesh Erosion in Over 10% of Users

Posted in Vaginal Mesh

Recently, a medical research team led by Peter S. Finamore evaluated the safety of transvaginal mesh, a type of synthetic tissue inserted through the vagina used to repair damaged areas of tissue in pelvic organ prolapsed (POP) and other ailments.  Reviewing a set of 124 patients who had undergone “mesh-augmented vaginal reconstructive surgery during an… Continue Reading

Research Shows: 10% Rate of Vaginal Mesh Erosion with TVM

Posted in Vaginal Mesh

A recent dialogue has begun in the medical community regarding the safety of transvaginal surgical mesh, a common product used to tread pelvic organ prolapse (POP) and stress urinary incontinence (SUI).  Believed to be inert and not to react with human tissue, the FDA now has received over 1000 complaints of adverse health effects caused by… Continue Reading

Duetact Diabetes Drug Linked to Bladder Cancer

Posted in Duetact

A 2011 repot has shown that use of diabetes drug Duetact® (glimepiride and pioglitazone), manufactured by Takeda Pharmaceuticals is associated with a dramatically-increased risk of bladder cancer.  Duetact®, a drug that works by increasing the body’s sensitivity to insulin, contains two chemicals proven to be carcinogenic: sulfonylurea and pioglitazone.  Sulfonylurea has been previously linked to… Continue Reading

Duetact Linked to Risk for Cancer and Major Cardiac Events

Posted in Duetact

Recently, an ingredient in Duetact®, a popular Type-II diabetes drug, has been found to be associated with an increased risk for bladder cancer.  While another research team (Piccinni et al, 2011) published a report linking pioglitazone to bladder cancer, this report, titled “Mortality and Other Important Diabetes-Related Outcomes With Insulin vs Other Antihyperglycemic Therapies in… Continue Reading

Humira Use Found to Raise Risk of Infection

Posted in Humira

In 2010, Astrid Wiens et al. published research in Pharmacotherapy demonstrating the danger of Humira®.  Humira® (adalimumab) is a type of TNF inhibitor, a class of chemicals which aim to kill tumor necrosis factor cells in the body.  As TNF cells cause inflammation, the killing of these cells alleviates inflammation in diseases such as rheumatoid arthritis,plaque psoriasis,… Continue Reading

Pradaxa Use Linked to Heart Attack

Posted in Pradaxa

Recently, an article published by Dr. Ken Uchiro et al in Archives of Internal Medicine reviews the relative safety of antibiotics commonly used today.  The drugs studied were Pradaxa® and warfarin; the risk for heart attack associated with the use of each drug was evaluated relative to other antibiotics and to the use of a… Continue Reading

Transvaginal Mesh Products Linked to Severe Adverse Health Effects

Posted in Vaginal Mesh

The United States Food and Drug Administration is currently reviewing the safety of transvaginal mesh products manufactured by Bard Medical, American Medical Systems, Boston Science Products, Ethicon, and Coloplast USA. The FDA comments: “In the last 3 years, the FDA has received over 1,000 adverse event reports about mesh used in transvaginal surgical repair of… Continue Reading

Pradaxa Shown to Cause Internal Bleeding in Elderly Users

Posted in Pradaxa

The prominent Philadelphia online news publication www.Philly.com has recently published an article investigating the safety of the popular anticoagulant drug, Pradaxa.  While medical researchers have already described the increased risk for heart attack associated with Pradaxa use, this article by Michael Cohen discusses new findings that have shown Pradaxa may cause internal bleeding in elderly patients…. Continue Reading

Pradaxa Found To Raise Risk of Heart Attack, Reuters Reports

Posted in Pradaxa

Recently, Reuters News has reported on serious risks associated with a popular anticoagulant drug, Pradaxa.  In particular, medical researchers have found that Pradaxa use dramatically raises risk of heart attack in some people.  For more information, read the full report on Pradaxa and heart attack here.